Literature DB >> 31216469

Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Jdp2-Jhdm1b-Mkk6-Glis1-Nanog-Essrb-Sall4.

Bo Wang1, Linlin Wu2, Dongwei Li1, Yuting Liu1, Jing Guo3, Chen Li4, Yuxiang Yao5, Yaofeng Wang1, Guoqing Zhao6, Xiaoshan Wang1, Meijun Fu4, He Liu1, Shangtao Cao1, Chuman Wu1, Shengyong Yu4, Chunhua Zhou4, Yue Qin4, Junqi Kuang4, Jin Ming4, Shilong Chu1, Xuejie Yang1, Ping Zhu7, Guangjin Pan1, Jiekai Chen1, Jing Liu8, Duanqing Pei9.   

Abstract

Reprogramming somatic cells to pluripotency by Oct4, Sox2, Klf4, and Myc represent a paradigm for cell fate determination. Here, we report a combination of Jdp2, Jhdm1b, Mkk6, Glis1, Nanog, Essrb, and Sall4 (7F) that reprogram mouse embryonic fibroblasts or MEFs to chimera competent induced pluripotent stem cells (iPSCs) efficiently. RNA sequencing (RNA-seq) and ATAC-seq reveal distinct mechanisms for 7F induction of pluripotency. Dropout experiments further reveal a highly cooperative process among 7F to dynamically close and open chromatin loci that encode a network of transcription factors to mediate reprogramming. These results establish an alternative paradigm for reprogramming that may be useful for analyzing cell fate control.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31216469     DOI: 10.1016/j.celrep.2019.05.068

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  17 in total

Review 1.  Chromatin accessibility dynamics during cell fate reprogramming.

Authors:  Dongwei Li; Xiaodong Shu; Ping Zhu; Duanqing Pei
Journal:  EMBO Rep       Date:  2021-01-22       Impact factor: 8.807

2.  MAP2K6 remodels chromatin and facilitates reprogramming by activating Gatad2b-phosphorylation dependent heterochromatin loosening.

Authors:  Guangsuo Xing; Zichao Liu; Luyuan Huang; Danyun Zhao; Tao Wang; Hao Yuan; Yi Wu; Linpeng Li; Qi Long; Yanshuang Zhou; Zhihong Hao; Yang Liu; Jianghuan Lu; Shiting Li; Jieying Zhu; Bo Wang; Junwei Wang; Jing Liu; Jiekai Chen; Duanqing Pei; Xingguo Liu; Keshi Chen
Journal:  Cell Death Differ       Date:  2021-11-24       Impact factor: 12.067

Review 3.  Regulation of Oct4 in stem cells and neural crest cells.

Authors:  Ivanshi Patel; Ronald J Parchem
Journal:  Birth Defects Res       Date:  2022-04-01       Impact factor: 2.661

4.  AP-1 activity is a major barrier of human somatic cell reprogramming.

Authors:  Yuting Liu; Jiangping He; Ruhai Chen; He Liu; Jocelyn Chen; Yujian Liu; Bo Wang; Lin Guo; Duanqing Pei; Jie Wang; Jing Liu; Jiekai Chen
Journal:  Cell Mol Life Sci       Date:  2021-06-28       Impact factor: 9.261

5.  ADAR1-Dependent RNA Editing Promotes MET and iPSC Reprogramming by Alleviating ER Stress.

Authors:  Diana Guallar; Alejandro Fuentes-Iglesias; Yara Souto; Cristina Ameneiro; Oscar Freire-Agulleiro; Jose Angel Pardavila; Adriana Escudero; Vera Garcia-Outeiral; Tiago Moreira; Carmen Saenz; Heng Xiong; Dongbing Liu; Shidi Xiao; Yong Hou; Kui Wu; Daniel Torrecilla; Jochen C Hartner; Miguel G Blanco; Leo J Lee; Miguel López; Carl R Walkley; Jianlong Wang; Miguel Fidalgo
Journal:  Cell Stem Cell       Date:  2020-05-11       Impact factor: 24.633

6.  Efficient induction of neural progenitor cells from human ESC/iPSCs on Type I Collagen.

Authors:  Pengfei Liu; Shubin Chen; Yaofeng Wang; Xiaoming Chen; Yiping Guo; Chunhua Liu; Haitao Wang; Yifan Zhao; Di Wu; Yongli Shan; Jian Zhang; Chuman Wu; Dongwei Li; Yanmei Zhang; Tiancheng Zhou; Yaoyu Chen; Xiaobo Liu; Chenxu Li; Lihui Wang; Bei Jia; Jie Liu; Bo Feng; Jinglei Cai; Duanqing Pei
Journal:  Sci China Life Sci       Date:  2021-03-16       Impact factor: 6.038

7.  Identification of Optimal Expression Parameters and Purification of a Codon-Optimized Human GLIS1 Transcription Factor from Escherichia coli.

Authors:  Chandrima Dey; Vishalini Venkatesan; Rajkumar P Thummer
Journal:  Mol Biotechnol       Date:  2021-09-15       Impact factor: 2.695

8.  Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma.

Authors:  Johannes Gojo; Bernhard Englinger; Li Jiang; Jens M Hübner; McKenzie L Shaw; Olivia A Hack; Sibylle Madlener; Dominik Kirchhofer; Ilon Liu; Jason Pyrdol; Volker Hovestadt; Emanuele Mazzola; Nathan D Mathewson; Maria Trissal; Daniela Lötsch; Christian Dorfer; Christine Haberler; Angela Halfmann; Lisa Mayr; Andreas Peyrl; Rene Geyeregger; Benjamin Schwalm; Monica Mauermann; Kristian W Pajtler; Till Milde; Marni E Shore; Jack E Geduldig; Kristine Pelton; Thomas Czech; Orr Ashenberg; Kai W Wucherpfennig; Orit Rozenblatt-Rosen; Sanda Alexandrescu; Keith L Ligon; Stefan M Pfister; Aviv Regev; Irene Slavc; Walter Berger; Mario L Suvà; Marcel Kool; Mariella G Filbin
Journal:  Cancer Cell       Date:  2020-07-13       Impact factor: 31.743

Review 9.  Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells.

Authors:  Kenly Wuputra; Chia-Chen Ku; Deng-Chyang Wu; Ying-Chu Lin; Shigeo Saito; Kazunari K Yokoyama
Journal:  J Exp Clin Cancer Res       Date:  2020-06-03

10.  Identification of potential transcription factors that enhance human iPSC generation.

Authors:  Nuha T Swaidan; Salam Salloum-Asfar; Freshteh Palangi; Khaoula Errafii; Nada H Soliman; Ahmed T Aboughalia; Abdul Haseeb S Wali; Sara A Abdulla; Mohamed M Emara
Journal:  Sci Rep       Date:  2020-12-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.